Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 13/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 13/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 13/20 | 0.38 |
| ▸ | HDAC7 | Q8WUI4 | 13/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 13/20 | 0.38 |
| ▸ | HDAC10 | Q969S8 | 13/20 | 0.38 |
| ▸ | HDAC11 | Q96DB2 | 13/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 13/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 13/20 | 0.38 |
| ▸ | HDAC9 | Q9UKV0 | 13/20 | 0.38 |
| ▸ | HDAC5 | Q9UQL6 | 13/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | PHGDH | O43175 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL35180 | 0.86 | — | — | |
| SCHEMBL11291272 | 0.78 | — | — | |
| SCHEMBL28307194 | 0.78 | — | — | |
| SCHEMBL31622922 | 0.75 | TDP1 (0.42) | ALDH1A1CYP1A2TSHRCYP2C19NOS3 | |
| SCHEMBL3463056 | 0.73 | — | — | |
| SCHEMBL14102731 | 0.71 | — | — | |
| SCHEMBL22657366 | 0.71 | NOS3 (0.46) | ALDH1A1CYP1A2TSHRCYP2C19NOS3 | |
| SCHEMBL18562073 | 0.71 | CYP1A2 (0.36) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL47735 | 0.71 | HDAC3 (0.42) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL11760685 | 0.69 | NOS3 (0.44) | HDAC3HDAC4HDAC1HDAC7HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025050013-A1 | COVALENT POLYMER-NUCLEIC ACID CONJUGATES FOR MODULATION OF THE RIG-I PATHWAY | VANDERBILT UNIVERSITY (US) | 2025-03-06 | — | — | WO | disclosed |
| US-11707483-B2 | Micellic assemblies | UNIVERSITY OF WASHINGTON (US) | 2023-07-25 | — | — | US | disclosed |
| US-20200147121-A1 | MICELLIC ASSEMBLIES | UNIVERSITY OF WASHINGTON (US) | 2020-05-14 | — | — | US | disclosed |
| US-10420790-B2 | Micellic assemblies | UNIVERSITY OF WASHINGTON (US) | 2019-09-24 | — | — | US | disclosed |
| US-10066043-B2 | ω-functionalized polymers, junction-functionalized block copolymers, polymer bioconjugates, and radical chain extension polymerization | UNIVERSITY OF WASHINGTON (US) | 2018-09-04 | — | — | US | disclosed |
| US-20180171056-A1 | DIBLOCK COPOLYMERS AND POLYNUCLEOTIDE COMPLEXES THEREOF FOR DELIVERY INTO CELLS | ROIVANT SCIENCES LTD. (GB) | 2018-06-21 | — | — | US | disclosed |
| US-9862792-B2 | Diblock copolymers and polynucleotide complexes thereof for delivery into cells | UNIVERSITY OF WASHINGTON (US) | 2018-01-09 | — | — | US | disclosed |
| US-20170239360-A1 | MICELLIC ASSEMBLIES | UNIVERSITY OF WASHINGTON (US) | 2017-08-24 | — | — | US | disclosed |
| US-9662403-B2 | Micellic assemblies | UNIVERSITY OF WASHINGTON (US) | 2017-05-30 | — | — | US | disclosed |
| US-20170145141-A1 | OMEGA-FUNCTIONALIZED POLYMERS, JUNCTION-FUNCTIONALIZED BLOCK COPOLYMERS, POLYMER BIOCONJUGATES, AND RADICAL CHAIN EXTENSION POLYMERIZATION | UNIVERSITY OF WASHINGTON (US) | 2017-05-25 | — | — | US | disclosed |
| US-7695892-B2 | Resist composition and pattern-forming method using same | FUJIFILM CORPORATION (JP) | 2010-04-13 | — | — | US | disclosed |
| US-7695892-B2 | Resist composition and pattern-forming method using same | FUJIFILM CORPORATION (JP) | 2010-04-13 | — | — | US | disclosed |
| WO-2010021770-A1 | HETEROGENEOUS POLYMERIC MICELLES FOR INTRACELLULAR DELIVERY | UNIVERSITY OF WASHINGTON (US) | 2010-02-25 | — | — | WO | disclosed |
| WO-2009140427-A2 | DIBLOCK COPOLYMERS AND POLYNUCLEOTIDE COMPLEXES THEREOF FOR DELIVERY INTO CELLS | UNIVERSITY OF WASHINGTON (US) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009140429-A2 | MICELLIC ASSEMBLIES | UNIVERSITY OF WASHINGTON (US) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009140432-A2 | MICELLES FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | UNIVERSITY OF WASHINGTON (US) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009140423-A2 | TARGETED POLYMER BIOCONJUGATES | UNIVERSITY OF WASHINGTON (US) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009140421-A2 | POLYMERIC CARRIER | UNIVERSITY OF WASHINGTON (US) | 2009-11-19 | — | — | WO | disclosed |
| US-20080241737-A1 | RESIST COMPOSITION AND PATTERN-FORMING METHOD USING SAME | FUJIFILM CORPORATION (JP) | 2008-10-02 | — | — | US | disclosed |
| US-20080241737-A1 | RESIST COMPOSITION AND PATTERN-FORMING METHOD USING SAME | FUJIFILM CORPORATION (JP) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11707483-B2 | Micellic assemblies | UACA, CLPTM1L, BPHL | HDAC3 4253/4885HDAC4 4874/4885HDAC1 4546/4885 |
| US-10420790-B2 | Micellic assemblies | UACA, CLPTM1L, BPHL | HDAC3 4253/4885HDAC4 4874/4885HDAC1 4546/4885 |
| US-20200147121-A1 | MICELLIC ASSEMBLIES | CLPX, VCL, ANXA5 | HDAC3 4196/4885HDAC4 4783/4885HDAC1 4629/4885 |
| US-20170239360-A1 | MICELLIC ASSEMBLIES | UACA, CLPTM1L, BPHL | HDAC3 4253/4885HDAC4 4874/4885HDAC1 4546/4885 |
| US-10066043-B2 | ω-functionalized polymers, junction-functionalized block copolymers, polymer bioconjugates, and radical chain extension polymerization | FASN, ALOX5, FGB | HDAC3 4064/4885HDAC4 4194/4885HDAC1 4805/4885 |
| US-20180171056-A1 | DIBLOCK COPOLYMERS AND POLYNUCLEOTIDE COMPLEXES THEREOF FOR DELIVERY INTO CELLS | CHMP4B, PHOSPHO1, EXOSC10 | HDAC3 4503/4885HDAC4 4404/4885HDAC1 4776/4885 |
| US-20170145141-A1 | OMEGA-FUNCTIONALIZED POLYMERS, JUNCTION-FUNCTIONALIZED BLOCK COPOLYMERS, POLYMER BIOCONJUGATES, AND RADICAL CHAIN EXTENSION POLYMERIZATION | FASN, ALOX5, ELOVL3 | HDAC3 4239/4885HDAC4 4323/4885HDAC1 4847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.